You can still register to the FREE Webinar organized with The Medicine Maker on Cutting-edge capillary electrophoresis characterization of therapeutic monoclonal antibodies and related products given by Dr. Yannis-Nicolas François on June 29th.
You can also attend the BIOPRODUCTION SEMINAR organized by Polepharma and Bio3 Institute in partnership with MabDesign and Medicen Paris Region, June 30th, Tours.
Cutting-edge capillary electrophoresis characterization of therapeutic monoclonal antibodies and related products June 29th, 16h00
MabDesign and The Medicine Maker are hosting a webinar in June 29th dedicated to the challenges and solutions of the last development of Capillary electrophoresis (CE) based methods for the characterization of mAbs and related products.
Dr Yannis-Nicolas François from the Strasbourg University will be giving the webinar and Stephanie Sutton, editor of The Medicine Maker will moderate the event and field your questions live.
20 Companies/Organizations will welcome you on the Exhibition Hall to show you their latest products/technology and services on therapeutic mAbs field!
More than 240 participants have already registered to this meeting representing more than 130 companies and organizations..
Do not miss this opportunity to connect and stablish new collaborations/partnerships!
The BtoB platform is OPEN.
More than 250 Meetings requested.
What about you?
The 4th Antibody Industrial Symposium is the place where antibody companies, scientific researchers, clinicians and technology suppliers will meet and discuss around current and next generation antibody formats.
The scientific committee has set-up an exciting program with keynote lectures, pitch talks on new creative projects, and industrial talks from pharma industries.
Immunogenicity & Tolerance Seminar October 24th, Hilton Apollolaan - Amsterdam
Platine and EpiVax are co-organizing their 2nd seminar on Immunogenicity and Tolerance on October 24th, 2016. This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics.
Speakers already confirmed:
-Elly Van Riet, PhD -Senior Scientist, Intravacc
-Prof. Annie De Groot, MD -Professor and Director,Institute of Immunology and Informatics, University of Rhode Island, CEO/CSO, EpiVax, Inc.
-Wim Jiskoot, PhD- Professor of Drug Development Leiden University Medical Center
-Marieke Van Ham, PhD- Immunopathology Department Head Sanquin
-Kees Melief, PhD - Chief Scientific Officer, ISA Pharma